Login
Toggle navigation
Videos
Categories
Trending
BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
BUSINESS TALK YEARLY 2020 By Torn Pracharktam, CEO of Thai Optical Group Pcl
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Latin Resources: Salinas Lithium Project Progress and Expansion Plans
00:10:00
Volta Metals' High-Grade Lithium Discovery in Northwestern Ontario Poised for Growth
00:10:00
Christophe Gurtner on Forsee Power's Goal to Triple Its Business |Christophe Gurtner,CEO , Forsee Power SA.
00:10:00
Fueling Growth: HR, Talent, and Culture in the Startup Ecosystem | Paul J. Sarvadi - CEO & Chairman of Insperity, Inc.
00:10:00
Sanjay Purohit on Sapphire Foods India's IPO and Growth Journey | Sanjay Purohit, CEO, Sapphire Foods India Ltd.
00:10:00
Energy Fuels CEO Mark Chelmer Discusses Strong Financial Position and Strategic Growth in Uranium Market
00:10:00
Chesapeake Gold's Matatus Project: Advancing a World-Class Gold-Silver Deposit with Strategic Development
00:10:00
Tax Strategies Unveiled: Maximizing Wealth with Roth Conversions - Chris Hostetler | Hilltop Wealth Advisors
00:10:00
NYSE Floor Talk features Sprinklr Founder & CEO Ragy Thomas.|Sprinklr Founder and CEO Ragy Thomas
00:10:00
Vox Royalty CEO Discusses 2023 Growth and Future Outlook
00:10:00
Presentation on Orca Gold's African Mining Ventures
00:10:00
Introducing From Startup to Centaur a Bessemer Book|David Cowan,Partner,Bessemer Venture Partners